Bioinformatics and Quantitative Structure-Property Relationship (QSPR) models

Current Bioinformatics

Volumn 8, Issue 4, 2013, Pages 387-389

  González Díaz, Humberto ^a,b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b BASQUE FOUNDATION FOR SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

QUANTITATIVE STRUCTURE-PROPERTY RELATIONSHIP MODELS;

BIOINFORMATICS;

BIOINFORMATICS; COMPUTER PROGRAM; EDITORIAL; PRIORITY JOURNAL; QUANTITATIVE PROTEOME PROPERTY RELATIONSHIP; QUANTITATIVE SEQUENCE ACTION MODEL; QUANTITATIVE STRUCTURE PROPERTY RELATION; QUANTITATIVE STRUCTURE REACTIVITY RELATIONSHIP; QUANTITATIVE STRUCTURE TOXICITY RELATIONSHIP; STRUCTURE ACTIVITY RELATION;

EID: 84882738029     PISSN: 15748936     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574893611308040001     Document Type: Editorial

References (44)

1. Caballero J, Fernandez M. Artificial neural networks from MATLAB in medicinal chemistry. Bayesian-regularized genetic neural networks (BRGNN): application to the prediction of the antagonistic activity against human platelet thrombin receptor (PAR-1). Curr Top Med Chem 2008; 8: 1580-605.
2. Duardo-Sanchez A, Patlewicz G, Lopez-Diaz A. Current topics on software use in medicinal chemistry: intellectual property, taxes, and regulatory issues. Curr Top Med Chem 2008; 8: 1666-75.
3. Gonzalez MP, Teran C, Saiz-Urra L, Teijeira M.Variable selection methods in QSAR: an overview. Curr Top Med Chem 2008; 8: 1606-27.
4. Gonzalez-Diaz H. Quantitative studies on Structure-Activity and Structure-Property Relationships (QSAR/QSPR). Curr Top Med Chem 2008; 8: 1554.
5. Gonzalez-Diaz H, Prado-Prado F, Ubeira F. M.Predicting antimicrobial drugs and targets with the MARCH-INSIDE approach. Curr Top Med Chem 2008; 8: 1676-90.
6. Helguera AM, Combes RD, Gonzalez MP, Cordeiro MN. Applications of 2D descriptors in drug design: a DRAGON tale. Curr Top Med Chem 2008; 8: 1628-55.
7. Ivanciuc O. Weka machine learning for predicting the phospholipidosis inducing potential. Curr Top Med Chem 2008; 8: 1691-709.
8. Vilar S, Cozza G, Moro S. Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery. Curr Top Med Chem 2008; 8: 1555-72.
9. Wang JF, Wei DQ, Chou KC. Drug candidates from traditional chinese medicines. Curr Top Med Chem 2008; 8: 1656-65.
10. Wang JF, Wei DQ, Chou KC. Pharmacogenomics and personalized use of drugs. Curr Top Med Chem 2008; 8: 1573-9.
11. Torrens F, Castellano G. Topological charge-transfer indices: from small molecules to proteins. Curr Proteomics 2009; 204-213.
12. Ivanciuc O. Machine learning Quantitative Structure-Activity Relationships (QSAR) for peptides binding to Human Amphiphysin-1 SH3 domain. Curr Proteomics 2009; 4: 289-302.
13. Giuliani A, Di Paola L, Setola R. Proteins as Networks: A mesoscopic approach using haemoglobin molecule as case study. Curr Proteomics 2009; 6: 235-245.
14. Chou KC. Pseudo amino acid composition and its applications in bioinformatics, proteomics and system biology. Curr Proteomics 2009; 6: 262-274.
15. Chen J, Shen B. Computational analysis of amino acid mutation: a proteome wide perspective. Curr Proteomics 2009; 6: 228-234.
16. Zhong WZ, Zhan J, Kang P, Yamazaki S. Gender specific drug metabolism of PF-02341066 in rats--role of sulfoconjugation. Curr Drug Metab 2010; 11: 296-306.
17. Wang JF, Chou KC. Molecular modeling of cytochrome P450 and drug metabolism. Curr Drug Metab 2010; 11: 342-6.
18. Mrabet Y, Semmar N. Mathematical methods to analysis of topology, functional variability and evolution of metabolic systems based on different decomposition concepts. Curr Drug Metab 2010; 11: 315-41.
19. Martinez-Romero M, Vazquez-Naya JM, Rabunal JR, et al. Artificial intelligence techniques for colorectal cancer drug metabolism: ontology and complex network. Curr Drug Metab 2010; 11: 347-68.
20. Khan MT. Predictions of the ADMET properties of candidate drug molecules utilizing different QSAR/QSPR modelling approaches. Curr Drug Metab 2010; 11: 285-95.
21. Gonzalez-Diaz H, Duardo-Sanchez A, Ubeira FM, et al. Review of March-Inside & complex networks prediction of drugs: ADMET, anti-parasite activity, metabolizing enzymes and cardiotoxicity proteome biomarkers. Curr Drug Metab 2010; 11: 379-406.
22. Gonzalez-Diaz H. Network topological indices, drug metabolism, and distribution. Curr Drug Metab 2010; 11: 283-4.
23. Garcia I, Diop YF, Gomez G. QSAR & complex network study of the HMGR inhibitors structural diversity. Curr Drug Metab 2010; 11: 307-14.
24. Chou KC. Graphic rule for drug metabolism systems. Curr Drug Metab 2010; 11: 369-78.
25. Concu R, Podda G, Ubeira FM, Gonzalez-Diaz H. Review of QSAR models for enzyme classes of drug targets: Theoretical background and applications in parasites, hosts, and other organisms. Curr Pharma Design 2010; 16: 2710-23.
26. Estrada E, Molina E, Nodarse D, Uriarte E. Structural Contributions of Substrates to their Binding to P-Glycoprotein. A Tops-Mode Approach Current Pharm Design 2010; 16: 2676-709.
27. Garcia I, Fall Y, Gomez G. QSAR, docking, and CoMFA studies of GSK3 inhibitors. Curr Pharm Design 2010; 16: 2666-75.
28. Gonzalez-Diaz H. QSAR and complex networks in pharmaceutical design, microbiology, parasitology, toxicology, cancer, and neurosciences. Curr Pharma Design 2010; 16: 2598-600.
29. Gonzalez-Diaz H, Romaris F, Duardo-Sanchez A, et al. Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications, and legal issues. Curr Pharma Design 2010; 16: 2737-64.
30. Marrero-Ponce Y, Casanola-Martin GM, Khan MT, Torrens F, Rescigno A, Abad C. Ligand-based computer-aided discovery of tyrosinase inhibitors. Applications of the Tomocomd-Cardd method to the elucidation of new compounds. Curr Pharma Design 2010; 16: 2601-24.
31. Munteanu CR, Fernandez-Blanco E, Seoane JA, et al. Drug discovery and design for complex diseases through QSAR computational methods. Curr Pharma Design 2010; 16: 2640-55.
32. Roy K, Ghosh G. Exploring QSARs with Extended Topochemical Atom (ETA) indices for modeling chemical and drug toxicity. Curr Pharma Design 2010; 16: 2625-39.
33. Speck-Planche A, Scotti MT, de Paulo-Emerenciano V. Current pharmaceutical design of antituberculosis drugs: future perspectives. Curr Pharma Design 2010; 16: 2656-65.
34. Vazquez-Naya JM, Martinez-Romero M, Porto-Pazos AB, et al. Ontologies of drug discovery and design for neurology, cardiology and oncology. Curr Pharma Design 2010; 16: 2724-36.
35. García I, Fall Y, Gómez G. Trends in Bioinformatics and Chemoinformatics of Vitamin D analogues and their protein targets. Curr Bioinform 2011; 6: 16-24.
36. Chiş O, Dumitru O, Concu R, Shen B. Reviewing Yeast Network and report of new Stochastic-Credibility cell cycle models. Curr Bioinform 2011; 6: 35-43.
37. Duardo-Sanchez A, Patlewicz G, González-Díaz H. A Review of Network Topological Indices from Chem-Bioinformatics to Legal Sciences and back. Curr Bioinform 2011; 6: 53-70.
38. Bhattacharjee B, Jayadeepa RM, Banerjee S, et al. Review of Complex Network and Gene Ontology in pharmacology approaches: Mapping natural compounds on potential drug target Colon Cancer network. Curr Bioinform 2011; 6: 44-52.
39. Prado-Prado F, Escobar-Cubiella M, García-Mera, X. Review of Bioinformatics and QSAR studies of β-secretase inhibitors. Curr Bioinform 2011; 6: 3-15.
40. Ivanciuc T, Ivanciuc O, Klein DJ. Network-QSAR with Reaction Poset Quantitative Superstructure-Activity Relationships (QSSAR) for PCB Chromatographic Properties. Curr Bioinform 2011; 6: 25-34.
41. Wan SB, Hu LL, Niu S, Wang K, Cai YD, Lu WC, Chou KC. Identification of multiple subcellular locations for proteins in budding yeast. Curr Bioinform 2011; 6: 71-80.
42. Riera-Fernández P, Munteanu CR, Pedreira-Souto N, Martín-Romalde R, Duardo-Sanchez A, González-Díaz H. Definition of Markov-Harary Invariants and Review of Classic Topological Indices and Databases in Biology, Parasitology, Technology, and Social-Legal Networks. Curr Bioinform 2011; 6: 94-121.
43. Dave K, Banerjee A. Bioinformatics analysis of functional relations between CNPs regions. Curr Bioinform 2011; 6: 122-128.
44. Speck-Planche A, Cordeiro MNDS. Application of Bioinformatics for the search of novel anti-viral therapies: Rational design of anti-herpes agents. Curr Bioinform 2011; 6: 81-93.